SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.83 0.26
(0.29%)

EUR-INR

105.77 0.25
(0.24%)

GBP-INR

121.29 0.43
(0.36%)

JPY-INR

0.58 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Alpa Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532878

INE385I01010

92.0499891

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALPA

8.55

160.96

EPS(TTM)

Face Value()

Div & Yield %

8.95

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	112.45	108.74	92.96	112.27	97.55	85.97
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	112.45	108.74	92.96	112.27	97.55	85.97
Other Income	23.31	14.87	9.41	10.79	4.41	2.97
Stock Adjustments	1.45	0.64	-1.27	-0.53	1.15	0.42
Total Income	137.21	124.25	101.10	122.53	103.11	89.36
EXPENDITURE :
Raw Materials	71.65	68.68	53.67	69.24	60.62	51.42
Power & Fuel Cost	2.84	3.02	3.04	2.64	2.43	2.21
Employee Cost	14.37	13.26	12.17	11.93	11.75	11.82
Other Manufacturing Expenses	3.43	3.62	3.69	3.69	2.86	2.07
Selling & Administrative Expenses	10.90	8.64	7.42	8.29	7.56	8.79
Miscellaneous Expenses	5.71	4.02	3.62	5.25	5.79	6.64
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	108.90	101.24	83.60	101.04	91.00	82.94
Operating Profit	28.31	23.02	17.48	21.48	12.12	6.42
Interest	0.27	0.39	0.22	0.24	0.10	0.20
Gross Profit	28.04	22.63	17.26	21.24	12.02	6.22
Depreciation	2.20	1.95	1.33	1.66	1.23	1.14
Profit Before Tax	25.84	20.68	15.93	19.58	10.79	5.08
Tax	4.06	3.00	3.60	3.10	2.39	1.75
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	2.10	0.90	-0.29	2.35	1.14	-0.75
Reported Net Profit	19.68	16.78	12.62	14.13	7.26	4.08
Extraordinary Items	-0.04	-0.43	-0.01	6.38	2.10	-1.31
Adjusted Net Profit	19.72	17.21	12.63	7.75	5.16	5.39
Adjustment below Net Profit	0.15	0.08	0.85	0.00	0.03	0.03
P & L Balance brought forward	85.97	69.11	55.64	41.51	34.23	30.13
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	105.80	85.97	69.11	55.64	41.52	34.23
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	9.35	7.97	6.00	6.71	3.45	1.94
Earnings Per Share(Adj)-Unit Curr	9.35	7.97	6.00	6.71	3.45	1.94
Book Value-Unit Curr	86.41	76.98	68.97	62.56	55.85	52.39
Book Value(Adj)-Unit Curr	86.41	76.98	68.97	62.56	55.85	52.39

85,041.45 -367.25 ( -0.43%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.83 0.26 (0.29%)

105.77 0.25 (0.24%)

121.29 0.43 (0.36%)

0.58 0.00 (0.43%)